ask="N/A"
ask_size="N/A"
average_daily_volume="188323"
bid="17.65"
bid_size="2100"
book_value="7.04"
change="-0.60"
change_from_200_day_moving_average="4.52"
change_from_50_day_moving_average="0.33"
change_from_52_week_high="-3.05"
change_From_52_week_low="8.90"
change_in_percent="-2.75%"
close="21.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-79.91M"
eps_estimate_current_year="-3.17"
eps_estimate_next_quarter="-0.92"
eps_estimate_next_year="-3.33"
ex_dividend_date="N/A"
float_shares="18634000"
high="21.95"
high_52_weeks="24.30"
last_trade_date="2/6/2017"
last_trade_price="21.25"
last_trade_size="12821"
last_trade_time="4:00pm"
low="21.15"
low_52_weeks="12.35"
market_capitalization="605.94M"
moving_average_200_day="16.73"
moving_average_50_day="20.92"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="36.60"
open="21.85"
pe_ratio="N/A"
peg_ratio="-0.59"
percent_change_from_200_day_moving_average="+27.01%"
percent_change_from_50_day_moving_average="+1.58%"
percent_change_from_52_week_high="-12.55%"
percent_change_from_52_week_low="+72.06%"
previous_close="21.85"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.10"
price_per_sales="2076.84"
revenue="300000.00"
shares_outstanding="28515000"
short_ratio="22.14"
stock_exchange="NGM"
symbol="RVNC"
volume="100533"
weeks_range_52="12.35 - 24.30"
